Principal Scientist, Oncology Translational Science and Clinical Biomarkers
2 days ago
Rahway
Working with ADT’s, early- & late-stage clinical development teams, the BMx leads will develop asset-specific clinical biomarker strategy by incorporating critical insight from discovery biology, clinical development, diagnostics, bioinformatics, molecular assay experts, QP2 and BARDS. Working